Skip Navigation

Human Molecular Genetics 2006 15(4):665; doi:10.1093/hmg/ddi488
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bett, J. S.
Right arrow Articles by Bates, G. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bett, J. S.
Right arrow Articles by Bates, G. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

CORRIGENDUM

Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG{gamma} as a therapeutic target

John S. Bett, Geoffrey M. Goellner, Ben Woodman, Gregory Pratt, Martin Rechsteiner and Gillian P. Bates

Human Molecular Genetics (2006) 15, 33–44; doi:10.1093/hmg/ddi423

The first 10% of the full text of this article appears below.

This figure has been reproduced as a corrigendum because the upper and lower panels of Figure 2B were . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?